Immune microenvironment composition in non‐small cell lung cancer and its association with survival

Abstract Objectives In non‐small cell lung cancer (NSCLC), the immune system and possibly its composition affect survival. In this in silico study, the immune infiltrate composition in NSCLC patients was evaluated. Methods Gene expression data of tumors from early NSCLC patients were obtained from G...

Full description

Bibliographic Details
Main Authors: Menno Tamminga, Thijo Jeroen N Hiltermann, Ed Schuuring, Wim Timens, Rudolf SN Fehrmann, Harry JM Groen
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Clinical & Translational Immunology
Subjects:
Online Access:https://doi.org/10.1002/cti2.1142
id doaj-900de82e78564084829bf0d7c620ad6a
record_format Article
spelling doaj-900de82e78564084829bf0d7c620ad6a2020-11-25T03:29:05ZengWileyClinical & Translational Immunology2050-00682020-01-0196n/an/a10.1002/cti2.1142Immune microenvironment composition in non‐small cell lung cancer and its association with survivalMenno Tamminga0Thijo Jeroen N Hiltermann1Ed Schuuring2Wim Timens3Rudolf SN Fehrmann4Harry JM Groen5Department of Pulmonary Diseases University Medical Center Groningen University of Groningen Groningen The NetherlandsDepartment of Pulmonary Diseases University Medical Center Groningen University of Groningen Groningen The NetherlandsDepartment of Pathology and Medical Biology University Medical Center Groningen University of Groningen Groningen The NetherlandsDepartment of Pathology and Medical Biology University Medical Center Groningen University of Groningen Groningen The NetherlandsDepartment of Medical Oncology University Medical Center Groningen University of Groningen Groningen The NetherlandsDepartment of Pulmonary Diseases University Medical Center Groningen University of Groningen Groningen The NetherlandsAbstract Objectives In non‐small cell lung cancer (NSCLC), the immune system and possibly its composition affect survival. In this in silico study, the immune infiltrate composition in NSCLC patients was evaluated. Methods Gene expression data of tumors from early NSCLC patients were obtained from Gene Expression Omnibus (GEO). With CIBERSORT, 22 immune cell fractions were estimated. Results The immune infiltrate of 1430 pretreatment NSCLC patients contained mostly plasma cells, macrophages and CD8 T cells. Higher fractions of resting mast and CD4 T‐helper cells were associated with longer overall survival (OS) (HR = 0.95, P < 0.01; HR = 0.98, = 0.04, respectively) and higher fractions of M2 macrophages and active dendritic cells with shorter survival (HR = 1.02, P = 0.03; HR = 1.03, P = 0.05, respectively). Adenocarcinoma patients with survival data (n = 587) showed higher fractions of resting mast and resting CD4 T cells, and lower M0 macrophages than squamous cell carcinoma (n = 254), which were associated with OS (HR = 0.95, P = 0.04; HR = 0.97, P = 0.01; HR = 1.03, P = 0.01, respectively). Fractions of memory B cells, naïve CD4 T cells and neutrophils had different associations with survival depending on the subtype. Smokers had had higher fractions of regulatory T cell, follicular helper T cell, neutrophil and M2 macrophage, which were associated with shorter survival (HR = 1.3, P < 0.01; HR = 1.13, P = 0.02; HR = 1.09, P = 0.03; HR = 1.04, P = 0.02, respectively). Conclusion Pretreatment differences in immune cell composition in NSCLC are associated with survival and depend on smoking status and histological subtype. Smokers' immune composition is associated with lower survival.https://doi.org/10.1002/cti2.1142adenocarcinomabiostatisticsimmune microenvironmentnon‐small cell lung cancersmokingsquamous cell carcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Menno Tamminga
Thijo Jeroen N Hiltermann
Ed Schuuring
Wim Timens
Rudolf SN Fehrmann
Harry JM Groen
spellingShingle Menno Tamminga
Thijo Jeroen N Hiltermann
Ed Schuuring
Wim Timens
Rudolf SN Fehrmann
Harry JM Groen
Immune microenvironment composition in non‐small cell lung cancer and its association with survival
Clinical & Translational Immunology
adenocarcinoma
biostatistics
immune microenvironment
non‐small cell lung cancer
smoking
squamous cell carcinoma
author_facet Menno Tamminga
Thijo Jeroen N Hiltermann
Ed Schuuring
Wim Timens
Rudolf SN Fehrmann
Harry JM Groen
author_sort Menno Tamminga
title Immune microenvironment composition in non‐small cell lung cancer and its association with survival
title_short Immune microenvironment composition in non‐small cell lung cancer and its association with survival
title_full Immune microenvironment composition in non‐small cell lung cancer and its association with survival
title_fullStr Immune microenvironment composition in non‐small cell lung cancer and its association with survival
title_full_unstemmed Immune microenvironment composition in non‐small cell lung cancer and its association with survival
title_sort immune microenvironment composition in non‐small cell lung cancer and its association with survival
publisher Wiley
series Clinical & Translational Immunology
issn 2050-0068
publishDate 2020-01-01
description Abstract Objectives In non‐small cell lung cancer (NSCLC), the immune system and possibly its composition affect survival. In this in silico study, the immune infiltrate composition in NSCLC patients was evaluated. Methods Gene expression data of tumors from early NSCLC patients were obtained from Gene Expression Omnibus (GEO). With CIBERSORT, 22 immune cell fractions were estimated. Results The immune infiltrate of 1430 pretreatment NSCLC patients contained mostly plasma cells, macrophages and CD8 T cells. Higher fractions of resting mast and CD4 T‐helper cells were associated with longer overall survival (OS) (HR = 0.95, P < 0.01; HR = 0.98, = 0.04, respectively) and higher fractions of M2 macrophages and active dendritic cells with shorter survival (HR = 1.02, P = 0.03; HR = 1.03, P = 0.05, respectively). Adenocarcinoma patients with survival data (n = 587) showed higher fractions of resting mast and resting CD4 T cells, and lower M0 macrophages than squamous cell carcinoma (n = 254), which were associated with OS (HR = 0.95, P = 0.04; HR = 0.97, P = 0.01; HR = 1.03, P = 0.01, respectively). Fractions of memory B cells, naïve CD4 T cells and neutrophils had different associations with survival depending on the subtype. Smokers had had higher fractions of regulatory T cell, follicular helper T cell, neutrophil and M2 macrophage, which were associated with shorter survival (HR = 1.3, P < 0.01; HR = 1.13, P = 0.02; HR = 1.09, P = 0.03; HR = 1.04, P = 0.02, respectively). Conclusion Pretreatment differences in immune cell composition in NSCLC are associated with survival and depend on smoking status and histological subtype. Smokers' immune composition is associated with lower survival.
topic adenocarcinoma
biostatistics
immune microenvironment
non‐small cell lung cancer
smoking
squamous cell carcinoma
url https://doi.org/10.1002/cti2.1142
work_keys_str_mv AT mennotamminga immunemicroenvironmentcompositioninnonsmallcelllungcanceranditsassociationwithsurvival
AT thijojeroennhiltermann immunemicroenvironmentcompositioninnonsmallcelllungcanceranditsassociationwithsurvival
AT edschuuring immunemicroenvironmentcompositioninnonsmallcelllungcanceranditsassociationwithsurvival
AT wimtimens immunemicroenvironmentcompositioninnonsmallcelllungcanceranditsassociationwithsurvival
AT rudolfsnfehrmann immunemicroenvironmentcompositioninnonsmallcelllungcanceranditsassociationwithsurvival
AT harryjmgroen immunemicroenvironmentcompositioninnonsmallcelllungcanceranditsassociationwithsurvival
_version_ 1724580770977153024